Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial

BACKGROUND: To reduce onward falciparum malaria transmission, the World Health Organization recommends adding single low-dose (SLD) primaquine to artemisinin-based combination treatment in low transmission areas. However, uptake of this recommendation has been relatively slow given concerns about wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Raman, Jaishree, Allen, Elizabeth, Workman, Lesley, Mabuza, Aaron, Swanepoel, Hendrik, Malatje, Gillian, Frean, John, Wiesner, Lubbe, Barnes, Karen I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592007/
https://www.ncbi.nlm.nih.gov/pubmed/31234865
http://dx.doi.org/10.1186/s12936-019-2841-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592007/
https://www.ncbi.nlm.nih.gov/pubmed/31234865
http://dx.doi.org/10.1186/s12936-019-2841-8

Ejemplares similares